Last reviewed · How we verify
NCT07164508
Examining the Health Impact of and Promoting Sitting Light Volleyball in the Greater Bay Area
NA trial testing Sitting Light Volleyball Intervention in Physial Disabilities in 225 participants. Not yet recruiting.
31 December 2029
Quick facts
| Lead sponsor | Education University of Hong Kong |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | other |
| Enrollment | 225 |
| Start date | 1 July 2026 |
| Primary completion | 31 December 2029 |
| Estimated completion | 31 December 2029 |
| Sites | 1 location across Hong Kong |
Drugs / interventions tested
- Sitting Light Volleyball Intervention
- Group Seated Dance Intervention
Conditions studied
- Physial Disabilities — all drugs for Physial Disabilities →
Sponsor
Education University of Hong Kong
Who can join
18 and older, any sex, with Physial Disabilities. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The present study builds on the promising result of our SLVB pilot study with the aim to extend the works' impact by investigating the effectiveness of a SLVB intervention on the physical and psychological health outcomes in adults with physical disabilities in HKG by collecting quantitative and qualitative data in a larger sample (225 participants). The investigators hypothesize that the SLVB and Seated Dance (SD) interventions will improve physical and psychological health outcomes, and quality of life compared to the control group, with SLVB expected to be more effective than SD in enhancing health outcomes for PWPDs. Using the consolidated evidence on the benefits of SVLB from our research work, the investigators will promote SLVB in HKD and CHN by organizing i) train-the-trainer workshops (325 trainers trained), ii) SLVB classes (about 1270 PWPD in HKG and CHN) and iii) SLVB competitions in HKG and CHN (initial rounds of competition will be held across Hong Kong, Shenzhen and Guangzhou, with the finals to be held in Hong Kong, totaling to 408 participants). The investigators combine the evidenced benefits of SVLB with the Train-The-Trainer approach, suggested by the World Health Organization, to achieve community engagement and it is regarded as a solution to institutional barriers in promoting adapted physical activity. SLVB teaching aids will also be developed to promote the activities.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07164508
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Education University of Hong Kong trials
Trials by the same sponsor.
- NCT07444866 — Machine Learning Enabled Management of Behavioural and Psychological Symptoms of Dementia Intervention for Dementia Care · NA · not yet recruiting
- NCT07308613 — Developing and Testing a Machine Learning Enabled Mindfulness Intervention for Reducing Loneliness Among Hong Kong Chine · NA · not yet recruiting
- NCT07123064 — Alleviating Loneliness in Older Adults Living in Poverty: A Multi-level Intervention · NA · not yet recruiting
- NCT07262853 — Dual Executive Function Training Package · NA · recruiting
- NCT07149974 — Neurofeedback Training for Autistic Children · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07164508 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Education University of Hong Kong
- Last refreshed: 10 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07164508.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing